Sunrise Realty Trust, Inc.
SUNSReal EstateNASDAQREIT - Mortgage · Last scanned Jul 22, 2026
Scan Results
Daily timeframeSunrise Realty Trust, Inc. engages in commercial real estate lending business in the United States. The $109.4M market capitalization puts SUNS squarely in micro-cap range for its industry. The company focuses on originating commercial real estate (CRE) loans and providing capital to borrowers and sponsors with business plants collateralized by CRE assets.
Market Cap
$109.4M
Beta
1.17
P/E (TTM)
8.17
P/E (Fwd)
6.40
EPS (TTM)
$0.99
EPS (Fwd)
$1.26
ROE
7.2%
ROA
4.7%
Cash
$5.7M
Total Debt
$139.4M
Free CF
—
52W Change
-23.6%
Annual Financials
Cash vs Debt
Where SUNS stands vs its 150-day and 200-day moving averages
As of the July 15, 2026 close, SUNS finished 0.61% above its 150-day moving average ($8.21) and 1.20% below its 200-day moving average ($8.36). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.
Is SUNS overbought or oversold?
At the July 15, 2026 close, SUNS's RSI(14) was 53.1, in neutral territory (between 30 and 70). The MACD histogram was negative, so short-term momentum leaned bearish at that close. These readings are historical, refresh daily after market close, and are not investment advice.
The company holds $5.7M in cash, though total debt stands at $139.4M. This level of leverage is common in the industry but worth monitoring as interest rate conditions evolve. ROE of 7.2% points to modest capital efficiency, indicating how much profit the company produces per dollar of shareholder equity. ROA of 4.7% is on the lower side, which is common in asset-heavy industries. Revenue has grown from $10.8M (2024) to $26.4M (2025), reflecting a 143% increase over the period.
The debt-to-cash ratio suggests meaningful leverage on the balance sheet, a factor worth monitoring if credit conditions tighten. It is important to consider these factors alongside broader market conditions and individual financial goals when reviewing SUNS.